Ligand Pharmaceuticals Incorporated Deal History & Licensing Activity
Ligand Pharmaceuticals Incorporated is a life sciences. Over the past three years, Ligand Pharmaceuticals Incorporated has been involved in 4 licensing and acquisition transactions, with a primary focus on Other (4 deals).
Deals (12mo)
2
Active Trials
0
Top Modality
Other
Focus Area
Mega Deals
Ligand Pharmaceuticals Incorporated Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Ligand Pharmaceuticals Incorporated in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| Zoma (corporate acquisition) | Ligan | Other | Unknown | acquisition | May 2026 |
| Zoma royalty portfolio | Ligand | Other | Unknown | acquisition | May 2026 |
| ZELSUVMI (berdazimer gel, 10.3%) | Pelthos Therapeutics Inc. | Small Molecules | Approved | license | Sep 2025 |
Ligand Pharmaceuticals Incorporated Pipeline Focus
Therapeutic areas and modalities where Ligand Pharmaceuticals Incorporated is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
See How Your Asset Matches Ligand Pharmaceuticals Incorporated's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Mega Deals assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Dermatology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for dermatology
Other Benchmarks
Upfront, milestone, and royalty benchmarks for other deals
Small Molecules Benchmarks
Upfront, milestone, and royalty benchmarks for small molecules deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
About Ligand Pharmaceuticals Incorporated Licensing & Deal Activity
Ligand Pharmaceuticals Incorporated is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 4 deals over the past three years, Ligand Pharmaceuticals Incorporated ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Ligand Pharmaceuticals Incorporated include Mega Deals (4 deals and trials), and Dermatology (4 deals and trials). In terms of modality, Ligand Pharmaceuticals Incorporated has shown particular interest in other, small molecules.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Ligand Pharmaceuticals Incorporated and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Ligand Pharmaceuticals Incorporated's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.